Literature DB >> 22442430

Role of cortisol in mood and memory in patients with intractable temporal lobe epilepsy.

R M Busch1, T Frazier, J S Chapin, A H Hamrahian, B Diehl, A Alexopoulos, K Unnwongse, R I Naugle, C S Kubu, G E Tesar, I M Najm.   

Abstract

OBJECTIVE: This study prospectively examined the relationships among late night salivary cortisol (NSC) levels and depressive symptoms, memory performance, and hippocampal volumes in patients with medically intractable temporal lobe epilepsy (TLE) and the potential mediating effects of cortisol in the relationships between these variables.
METHODS: Participants included 24 adults with well-characterized medically refractory TLE (right = 11; left = 12; bitemporal = 1). All patients provided saliva samples and completed measures of mood, anxiety, and memory (objective and subjective). MRI-based volumetric analyses of the hippocampi were also conducted.
RESULTS: As hypothesized, cortisol was found to be negatively related to several memory measures such that patients with higher cortisol levels demonstrated lower memory performance. However, unexpectedly, cortisol was not related to current symptoms of depression or anxiety, subjective memory ratings, or hippocampal volumes. Consistent with previous findings in the literature, a number of other relationships among the study variables were observed (objective memory and hippocampal volume; subjective memory and mood/anxiety). Results of mediator analyses suggested that cortisol does not mediate the relationship between depression and memory dysfunction or the relationship between depression and hippocampal atrophy.
CONCLUSIONS: While cortisol may play a role in memory performance in patients with TLE, it does not fully explain the relationship between depression and mesial temporal dysfunction, likely reflecting the complex and multifactorial relationships among these variables. Results confirm the relationship between memory performance and structural brain integrity and provide further support for a role of depression in subjective memory complaints.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442430      PMCID: PMC3466605          DOI: 10.1212/WNL.0b013e31824e8efb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  The value of interictal diffusion-weighted imaging in lateralizing temporal lobe epilepsy.

Authors:  T Wehner; E Lapresto; J Tkach; P Liu; W Bingaman; R A Prayson; P Ruggieri; B Diehl
Journal:  Neurology       Date:  2007-01-09       Impact factor: 9.910

2.  Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels.

Authors:  M L Rao; H Stefan; J Bauer
Journal:  Neuroendocrinology       Date:  1989-01       Impact factor: 4.914

3.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

4.  Cortisol hypersecretion and cognitive impairment in depression.

Authors:  D R Rubinow; R M Post; R Savard; P W Gold
Journal:  Arch Gen Psychiatry       Date:  1984-03

5.  Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis.

Authors:  Ty Carroll; Hershel Raff; James W Findling
Journal:  Endocr Pract       Date:  2009 May-Jun       Impact factor: 3.443

6.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

  6 in total
  2 in total

1.  Impact of surgical intervention on seizure and psychiatric symptoms in patients with temporal lobe epilepsy.

Authors:  Lokesh Shahani; Gregory Cervenka
Journal:  BMJ Case Rep       Date:  2019-07-27

2.  Subjective memory evaluation before and after temporal lobe epilepsy surgery.

Authors:  Chin-Wei Huang; Brent Hayman-Abello; Susan Hayman-Abello; Paul Derry; Richard S McLachlan
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.